9th Advances Against Aspergillosis and Mucormycosis Conference
Between the 27th and 29th February 2020, scientists from around the world will be meeting in Switzerland to discuss the latest developments in aspergillosis and mucormycosis research. At these conferences, participants have the opportunity to view posters and attend talks on the latest research, as well as meeting other experts in the field. The National Aspergillosis Centre team was planning on attending the event, however due to concerns about Corona virus this has not been possible. Instead, Graham has chosen a few posters that he thinks may be interesting to patients and carers, and he has explained these on video. View these videos by clicking on the links below (you must already be, or become a member of the Facebook support group to do so):
- Antimicrobial susceptibility of Aspergillus fumigatus and Stenotrophomonas maltophilia biofilms: did they find strength in unity?
- Does monitoring cyp51A-mediated triazole resistance in Aspergillus fumigatus by pyrosequencing lead to patient benefit?
- Antifungal liposomes targeted to fungal cells have dramatically increased efficacy
- Epithelial uptake of Aspergillus fumigatus spores drives efficient fungal clearance in vivo and is aberrant in Chronic Obstructive Pulmonary Disease (COPD) patients
Impact statements from people living with aspergillosis have also been displayed at the conference on World Aspergillosis Day, bringing patient voices to a largely academic event: